Engineering resistance to aliphatic alcohols
View Patent ↗The present disclosure provides improved systems for the biological production of aliphatic alcohol compounds. In particular, the present disclosure provides biological systems that show improved resistance to aliphatic alcohol toxicity; in some embodiments, such improved resistance allows for increased levels of aliphatic alcohol production. In one aspect, the present disclosure provides engineered microorganisms that both produce an aliphatic alcohol compound and show resistance to that compound as measured by an ability to grow to predetermined levels in the presence of a given concentration of the compound.
1. A recombinant microbial cell, characterized in that the recombinant microbial cell comprises at least one alcohol tolerance modification as compared with a parent cell, wherein the alcohol tolerance modification comprises introduction of a nucleic acid molecule comprising a 3′ untranslated region (UTR) of a gene encoding a CAAX protease polypeptide, and wherein the 3′ UTR comprises a nucleotide sequence having at least 90% identity to the nucleotide sequence of SEQ ID NO: 187.
2. The recombinant microbial cell of claim 1 , wherein the nucleic acid molecule comprises a 3′ UTR of a gene encoding a Lactobacillus CAAX protease polypeptide.
3. The recombinant microbial cell of claim 2 , wherein the 3′ UTR comprises the nucleotide sequence of SEQ ID NO: 187.
4. The recombinant microbial cell of claim 1 , wherein the nucleic acid molecule comprising the 3′ UTR further comprises a 5′ region of a gene encoding a CAAX protease polypeptide.
5. The recombinant microbial cell of claim 4 , wherein the 5′ region of the gene comprises a 5′ UTR.
6. The recombinant microbial cell of claim 4 , wherein the 5′ region of the gene comprises nucleotides immediately upstream of sequence encoding the CAAX protease polypeptide.
7. The recombinant microbial cell of claim 4 , wherein the nucleic acid molecule comprises a 5′ region of a gene encoding a Lactobacillus CAAX protease polypeptide.
8. The recombinant microbial cell of claim 7 , wherein the 5′ region of the gene comprises the nucleotide sequence of SEQ ID NO: 185.
9. The recombinant microbial cell of claim 1 , wherein the cell exhibits increased tolerance to butanol as compared with the parent cell.
10. The recombinant microbial cell of claim 9 , wherein the increased tolerance to butanol comprises an increased butanol IC 50 , wherein the IC 50 is increased at least 5%, 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 100%, or more.
11. The recombinant microbial cell of claim 9 or 10 , wherein the increased tolerance to butanol comprises increased carbohydrate utilization as compared to the parent cell when grown in the same amount of butanol.
12. The recombinant microbial cell of claim 11 , wherein the carbohydrate utilization is increased at least 5%, 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 100%, or more.
13. The recombinant cell of claim 1 , wherein the cell exhibits increased butanol production as compared with the parent cell.
14. The recombinant microbial cell of claim 1 , wherein the cell is a member of a genus selected from the group consisting of Clostridium, Zymomonas, Escherichia, Salmonella, Rhodococcus, Pseudomonas, Bacillus, Lactobacillus, Enterococcus, Alcaligenes, Klebsiella, Paenibacillus, Arthrobacter, Corynebacterium, Brevibacterium, Acinetobacter, Pichia, Candida, Hansenula , and Saccharomyces.